MedTrace Logo

Non Invasive Detection of Lung and Breast Cancer by Odor Signature

NCT02195076 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2014-07-21

No results posted yet for this study

Summary

The investigators have developed an early detection solution for lung and breast cancer. A system which can distinguish between different medical odors based on biosensors. Our product is user-friendly noninvasive, nonradioactive and nontoxic to the patients. The technology enables a high level of sensitivity and provides users with a quick lab response and a simple yes or no answer.

The aim of this study is to contribute and detect the patient at the earliest possible stage, in a noninvasive, nonradioactive and nontoxic way. Exhaled breath and urine samples are a promising approach towards future possible lung and breast cancer screening method.

Conditions

Interventions

OTHER

non-invasive detection of cancer odor

The odor VOCs of the specimens will be subjected to our system for detection by the biosensors. If the sample is cancerous the biosensors will report it (YES signal). If the sample s not cancerous, the biosensors will not report it (NO signal).

Sponsors & Collaborators

  • Sheba Medical Center

    collaborator OTHER_GOV

  • BioSense Medical LTD

    lead INDUSTRY

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2017-07-31

Countries

  • Israel

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02195076 on ClinicalTrials.gov